ANUH PHARMA
|
ANUH PHARMA Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹13 Cr |
Equity - Authorised | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr |
Equity - Issued | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹13 Cr |
Equity Paid Up | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹13 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹266 Cr | ₹216 Cr | ₹189 Cr | ₹166 Cr | ₹150 Cr |
Securities Premium | - | - | - | - | - |
Capital Reserves | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
Profit & Loss Account Balance | ₹157 Cr | ₹114 Cr | ₹93 Cr | ₹76 Cr | ₹54 Cr |
General Reserves | ₹109 Cr | ₹102 Cr | ₹95 Cr | ₹89 Cr | ₹96 Cr |
Other Reserves | ₹0.06 Cr | ₹0.09 Cr | ₹0.06 Cr | ₹-0.03 Cr | ₹-0.03 Cr |
Reserve excluding Revaluation Reserve | ₹266 Cr | ₹216 Cr | ₹189 Cr | ₹166 Cr | ₹150 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹291 Cr | ₹241 Cr | ₹214 Cr | ₹191 Cr | ₹162 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-0.42 Cr | ₹-0.77 Cr | ₹0.05 Cr | ₹1.01 Cr | ₹0.21 Cr |
Deferred Tax Assets | ₹1.23 Cr | ₹1.04 Cr | ₹0.84 Cr | ₹1.01 Cr | ₹1.18 Cr |
Deferred Tax Liability | ₹0.81 Cr | ₹0.27 Cr | ₹0.89 Cr | ₹2.02 Cr | ₹1.39 Cr |
Other Long Term Liabilities | ₹0.39 Cr | ₹0.84 Cr | ₹0.91 Cr | - | ₹0.08 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹1.38 Cr | ₹1.58 Cr | ₹1.54 Cr | ₹1.51 Cr | ₹1.17 Cr |
Total Non-Current Liabilities | ₹1.35 Cr | ₹1.66 Cr | ₹2.50 Cr | ₹2.53 Cr | ₹1.46 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹141 Cr | ₹153 Cr | ₹122 Cr | ₹120 Cr | ₹105 Cr |
Sundry Creditors | ₹141 Cr | ₹153 Cr | ₹122 Cr | ₹120 Cr | ₹105 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹10 Cr | ₹8.50 Cr | ₹6.16 Cr | ₹5.76 Cr | ₹13 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹3.24 Cr | ₹3.13 Cr | ₹1.42 Cr | ₹0.66 Cr | ₹4.39 Cr |
Interest Accrued But Not Due | ₹0.02 Cr | - | ₹0.00 Cr | - | ₹0.16 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹6.78 Cr | ₹5.38 Cr | ₹4.75 Cr | ₹5.10 Cr | ₹8.76 Cr |
Short Term Borrowings | ₹2.01 Cr | - | ₹3.11 Cr | ₹14 Cr | ₹45 Cr |
Secured ST Loans repayable on Demands | ₹2.01 Cr | - | ₹3.11 Cr | ₹14 Cr | ₹45 Cr |
Working Capital Loans- Sec | - | - | - | ₹14 Cr | ₹45 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | - | ₹-14 Cr | ₹-45 Cr |
Short Term Provisions | ₹0.14 Cr | ₹0.07 Cr | ₹0.06 Cr | ₹0.10 Cr | ₹0.20 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.14 Cr | ₹0.07 Cr | ₹0.06 Cr | ₹0.10 Cr | ₹0.20 Cr |
Total Current Liabilities | ₹153 Cr | ₹161 Cr | ₹131 Cr | ₹139 Cr | ₹163 Cr |
Total Liabilities | ₹445 Cr | ₹404 Cr | ₹347 Cr | ₹333 Cr | ₹326 Cr |
ASSETS | |||||
Gross Block | ₹104 Cr | ₹100 Cr | ₹100 Cr | ₹98 Cr | ₹96 Cr |
Less: Accumulated Depreciation | ₹55 Cr | ₹47 Cr | ₹38 Cr | ₹27 Cr | ₹12 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹49 Cr | ₹53 Cr | ₹61 Cr | ₹71 Cr | ₹84 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹0.45 Cr | - | ₹0.10 Cr | - | - |
Non Current Investments | ₹42 Cr | ₹40 Cr | ₹21 Cr | ₹20 Cr | ₹14 Cr |
Long Term Investment | ₹42 Cr | ₹40 Cr | ₹21 Cr | ₹20 Cr | ₹14 Cr |
Quoted | ₹1.81 Cr | ₹1.81 Cr | ₹1.81 Cr | ₹1.81 Cr | ₹1.81 Cr |
Unquoted | ₹40 Cr | ₹38 Cr | ₹19 Cr | ₹19 Cr | ₹12 Cr |
Long Term Loans & Advances | ₹4.95 Cr | ₹4.11 Cr | ₹2.20 Cr | ₹2.62 Cr | ₹2.68 Cr |
Other Non Current Assets | ₹13 Cr | - | ₹3.55 Cr | ₹0.50 Cr | ₹3.00 Cr |
Total Non-Current Assets | ₹109 Cr | ₹97 Cr | ₹88 Cr | ₹95 Cr | ₹103 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹55 Cr | ₹51 Cr | ₹21 Cr | ₹11 Cr | ₹66 Cr |
Quoted | - | - | - | ₹4.95 Cr | - |
Unquoted | ₹55 Cr | ₹51 Cr | ₹21 Cr | ₹6.07 Cr | ₹66 Cr |
Inventories | ₹75 Cr | ₹73 Cr | ₹80 Cr | ₹81 Cr | ₹61 Cr |
Raw Materials | ₹37 Cr | ₹35 Cr | ₹46 Cr | ₹53 Cr | ₹31 Cr |
Work-in Progress | ₹11 Cr | ₹9.81 Cr | ₹7.97 Cr | ₹3.15 Cr | ₹3.78 Cr |
Finished Goods | ₹23 Cr | ₹9.71 Cr | ₹25 Cr | ₹25 Cr | ₹27 Cr |
Packing Materials | ₹0.18 Cr | ₹0.19 Cr | ₹0.14 Cr | ₹0.09 Cr | ₹0.07 Cr |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹3.10 Cr | ₹18 Cr | ₹0.29 Cr | ₹0.24 Cr | ₹0.15 Cr |
Sundry Debtors | ₹190 Cr | ₹171 Cr | ₹136 Cr | ₹107 Cr | ₹81 Cr |
Debtors more than Six months | ₹0.04 Cr | ₹0.37 Cr | ₹0.21 Cr | ₹0.40 Cr | - |
Debtors Others | ₹190 Cr | ₹171 Cr | ₹136 Cr | ₹107 Cr | ₹81 Cr |
Cash and Bank | ₹9.67 Cr | ₹6.65 Cr | ₹16 Cr | ₹20 Cr | ₹2.52 Cr |
Cash in hand | ₹0.01 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Balances at Bank | ₹9.66 Cr | ₹6.64 Cr | ₹16 Cr | ₹20 Cr | ₹2.50 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.97 Cr | ₹0.67 Cr | ₹1.00 Cr | ₹17 Cr | ₹7.32 Cr |
Interest accrued on Investments | ₹0.21 Cr | ₹0.09 Cr | ₹0.18 Cr | ₹0.10 Cr | ₹0.08 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | ₹0.23 Cr | ₹0.02 Cr | ₹0.05 Cr |
Prepaid Expenses | ₹0.59 Cr | ₹0.57 Cr | ₹0.48 Cr | ₹0.44 Cr | ₹0.27 Cr |
Other current_assets | ₹0.18 Cr | ₹0.02 Cr | ₹0.11 Cr | ₹16 Cr | ₹6.92 Cr |
Short Term Loans and Advances | ₹5.15 Cr | ₹5.27 Cr | ₹4.63 Cr | ₹1.53 Cr | ₹4.73 Cr |
Advances recoverable in cash or in kind | ₹2.35 Cr | ₹0.99 Cr | ₹0.08 Cr | ₹0.14 Cr | ₹0.34 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹2.80 Cr | ₹4.29 Cr | ₹4.55 Cr | ₹1.40 Cr | ₹4.39 Cr |
Total Current Assets | ₹336 Cr | ₹308 Cr | ₹259 Cr | ₹238 Cr | ₹223 Cr |
Net Current Assets (Including Current Investments) | ₹184 Cr | ₹146 Cr | ₹128 Cr | ₹98 Cr | ₹60 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹445 Cr | ₹404 Cr | ₹347 Cr | ₹333 Cr | ₹326 Cr |
Contingent Liabilities | ₹20 Cr | ₹29 Cr | ₹33 Cr | ₹23 Cr | ₹33 Cr |
Total Debt | ₹2.01 Cr | - | ₹3.11 Cr | ₹14 Cr | ₹45 Cr |
Book Value | 58.11 | 48.14 | 42.66 | 38.04 | 64.74 |
Adjusted Book Value | 58.11 | 48.14 | 42.66 | 38.04 | 32.37 |
Compare Balance Sheet of peers of ANUH PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ANUH PHARMA | ₹1,079.9 Cr | -2.2% | 9.1% | 52.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 0.7% | 47.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | -1.1% | -5.8% | 61.7% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | 0.3% | -1.8% | 19.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 6% | 11.8% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -1.5% | -0.1% | 47% | Stock Analytics |
ANUH PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ANUH PHARMA | -2.2% |
9.1% |
52.5% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses